Active Ingredient Inotuzumab Ozogamicin
Active Ingredient Details
What is Inotuzumab Ozogamicin?
Immunotoxin that consists of anti-CD22 (CD22 ANTIGEN) humanized monoclonal antibody covalently linked to the antineoplastic antibiotic CALICHEAMICIN. It is used for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (LEUKEMIA, ACUTE LYMPHOBLASTIC).
What is the usage for Inotuzumab Ozogamicin?
This medication is used to treat a certain type of cancer (acute lymphoblastic leukemia-ALL). It works by slowing or stopping the growth of cancer cells.
How many products in the NDC database contain Inotuzumab Ozogamicin?
The NDC database has 1 products with the active ingredient Inotuzumab Ozogamicin. The following table lists all the products that have this active ingredient.
NDC Products with Inotuzumab Ozogamicin
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0008-0100 | Proprietary Name: Besponsa | Inotuzumab Ozogamicin | Injection, Powder, Lyophilized, For Solution | Intravenous | Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc. | ACTIVE |